SCHEDULE 13G Filed 2026-05-29 Event — SEC 0000908834-26-000252 →

Farallon Capital Partners, L.P. → BridgeBio Pharma, Inc. BBIO

Stake: — Shares: — Class: Common Stock, par value $0.001 per share (the "Shares")

Composite Decision Signal · WATCH (DEVELOPING SETUP) Conviction Score: 52/100 · Filer 90d Win Rate: 67% · Hist. 90d Edge: -1.3%

Filer track record (3 filings): 67% 90d win rate, +1.1% 90d edge
Material 8-K governance/transaction event (Item 5.02 / 1.01 / 2.01) within ±30d
Held by 2 tracked 13F institutional managers
Congressional purchase disclosure (5 trades in ±90d)
Elevated short days-to-cover (7.7 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

11 13D/G filings on this issuer

10 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 7.68

19,997,556 shares short · +1.7% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers

2 holders · $741.60M

Point72 Asset MgmtViking Global

Other 13D/G Filings on BridgeBio Pharma, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-17	SCHEDULE 13D/A	KKR Genetic Disorder L.P.	—	8,260,971	view →
2026-07-10	SCHEDULE 13D/A	VIKING GLOBAL INVESTORS LP	5.00%	9,792,219	view →
2026-04-02	SCHEDULE 13D/A	VIKING GLOBAL INVESTORS LP	6.10%	11,842,434	view →
2025-07-01	SCHEDULE	VIKING GLOBAL INVESTORS LP	9.80%	18,602,920	view →
2025-05-14	SCHEDULE	KKR Genetic Disorder L.P.	7.00%	13,260,971	view →
2025-03-07	SCHEDULE	KKR Genetic Disorder L.P.	10.10%	19,260,971	view →
2025-01-31	SCHEDULE	VIKING GLOBAL INVESTORS LP	11.70%	22,055,375	view →
2023-07-20	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2021-01-26	SC	Eidos Therapeutics, Inc.	—	—	view →
2020-06-01	SC	KKR Genetic Disorder L.P.	—	—	view →

Other Filings by Farallon Capital Partners, L.P.

Filed	Form	Issuer	Stake	Shares
2026-01-05	SCHEDULE	EXELIXIS, INC. EXEL	5.90%	15,709,500	view →
2025-05-20	SCHEDULE	EXELIXIS, INC. EXEL	6.80%	18,635,500	view →
2025-03-05	SCHEDULE	EXELIXIS, INC. EXEL	8.40%	23,439,500	view →
2023-11-07	SC	Cazoo Group Ltd	—	—	view →
2023-04-27	SC	Cazoo Group Ltd	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →